Jaguar Health (JAGX) EPS (Basic) (2020 - 2026)
Jaguar Health (JAGX) posted quarterly EPS (Basic) of -$13.6 for Q1 2026, up 97.67% year-over-year from -$6.88 in Q1 2025, and up 96.09% quarter-over-quarter from -$348.03 in Q4 2025.
Jaguar Health (JAGX) EPS (Basic) (2020 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported EPS (Basic) for 7 consecutive years, with -$13.6 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 97.67% year-over-year to -$13.6; the TTM figure through Mar 2026 stood at -$97.75 (up 95.65% YoY), while the FY2025 annual figure was -$803.95, up 82.42% from the prior year.
- EPS (Basic) improved to -$13.6 in Q1 2026 per JAGX's latest filing, from -$348.03 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$13.6 in Q1 2026 and bottomed at -$1.6 million in Q1 2022.
- Historically, EPS (Basic) has averaged -$181364.0 across 5 years, with a median of -$3535.2 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 49.77% — and 2026, when it surged 97.67%.
- Jaguar Health's EPS (Basic) stood at -$303240.0 in 2022, then jumped by 93.11% to -$20888.4 in 2023, then jumped by 94.18% to -$1216.2 in 2024, then soared by 71.38% to -$348.03 in 2025, then soared by 96.09% to -$13.6 in 2026.
- Business Quant data shows JAGX's EPS (Basic) at -$13.6 in Q1 2026, -$348.03 in Q4 2025, and -$223.16 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Jaguar Health | 452,552.38 | -9.61 Mn | 19.11 Mn | -13.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.60 |
| Dec 31, 2025 | -348.03 |
| Sep 30, 2025 | -223.16 |
| Jun 30, 2025 | -364.21 |
| Mar 31, 2025 | -584.45 |
| Dec 31, 2024 | -1,216.16 |
| Sep 30, 2024 | -935.75 |
| Jun 30, 2024 | -3,535.20 |
| Mar 31, 2024 | -3,048.91 |
| Dec 31, 2023 | -20,888.38 |
| Sep 30, 2023 | -19,691.14 |
| Jun 30, 2023 | -36,160.71 |
| Mar 31, 2023 | -125,793.81 |
| Dec 31, 2022 | -303,240.00 |
| Sep 30, 2022 | -463,703.70 |
| Jun 30, 2022 | -468,350.00 |
| Mar 31, 2022 | -1.64 Mn |
| Dec 31, 2021 | -1.30 Mn |
| Sep 30, 2021 | -1.02 Mn |
| Jun 30, 2021 | -1.28 Mn |